| First Author | Sartori R | Year | 2013 |
| Journal | Nat Genet | Volume | 45 |
| Issue | 11 | Pages | 1309-18 |
| PubMed ID | 24076600 | Mgi Jnum | J:205290 |
| Mgi Id | MGI:5544527 | Doi | 10.1038/ng.2772 |
| Citation | Sartori R, et al. (2013) BMP signaling controls muscle mass. Nat Genet 45(11):1309-18 |
| abstractText | Cell size is determined by the balance between protein synthesis and degradation. This equilibrium is affected by hormones, nutrients, energy levels, mechanical stress and cytokines. Mutations that inactivate myostatin lead to excessive muscle growth in animals and humans, but the signals and pathways responsible for this hypertrophy remain largely unknown. Here we show that bone morphogenetic protein (BMP) signaling, acting through Smad1, Smad5 and Smad8 (Smad1/5/8), is the fundamental hypertrophic signal in mice. Inhibition of BMP signaling causes muscle atrophy, abolishes the hypertrophic phenotype of myostatin-deficient mice and strongly exacerbates the effects of denervation and fasting. BMP-Smad1/5/8 signaling negatively regulates a gene (Fbxo30) that encodes a ubiquitin ligase required for muscle loss, which we named muscle ubiquitin ligase of the SCF complex in atrophy-1 (MUSA1). Collectively, these data identify a critical role for the BMP pathway in adult muscle maintenance, growth and atrophy. |
